Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New lens implant could sharpen vision for kids with cataracts and astigmatism

NCT ID NCT06294795

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a toric intraocular lens implant in 40 children aged 6 to 17 with cataracts and astigmatism (a condition where the eye is shaped like a football). The goal was to see if this special lens could improve vision better than standard surgery. All children had cataract surgery with the toric lens placed in the eye. Researchers measured vision sharpness and eye curvature after surgery to see how well the lens corrected both problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
toric intraocular lens implant
What this could lead to
If successful, this could provide a standard way to correct both cataracts and astigmatism in children with a single surgery, improving long-term vision without glasses.
What could go wrong
This is a small, completed trial with only 40 participants, so results may not apply to all children. Risks include surgical complications or the lens not fully correcting astigmatism.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Mar 2024

Finished

Mar 2026

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. Visually significant cataract; 2. Corneal astigmatism more than 1.25 diopters; 3. Children aged ≥ 6 years and \< 18 years. Exclusion criteria: 1. Patients with a corneal diameter less than 9 mm; 2. Presence of corneal scarring; 3. Irregular astigmatism; 4. Intraocular pressure more than 25 mm Hg; 5. Active inflammatory process of the eyeball or signs of a previous episode of inflammation; 6. Traumatic, subluxated, or complicated cataract; 7. Persistent Fetal Vasculature; 8. Diseases of the optic nerve or macula that may limit visual potential; 9. History of previous intraocular surgeries; 10. Performing posterior capsulorhexis intraoperatively.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Astigmatism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kazakh Eye Research Institute

    Almaty, 050012, Kazakhstan

  • Kazakh Eye Research Institute

    Astana, 010000, Kazakhstan

More trials for these conditions

Other studies related to the condition(s) this trial covers.